Piper Sandler Maintains Overweight on IDEXX Laboratories, Raises Price Target to $525
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst David Westenberg maintains an Overweight rating on IDEXX Laboratories (NASDAQ:IDXX) and raises the price target from $520 to $525.
November 06, 2023 | 3:19 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Piper Sandler maintains an Overweight rating on IDEXX Laboratories and raises the price target from $520 to $525, indicating a positive outlook for the company.
The raised price target by Piper Sandler indicates a positive outlook for IDEXX Laboratories. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100